• Home
• About CACO-Bay Area
• Join
  • Join Free!
  • Update Account Info
• Events
  • Event Registration
  • Event Types
    • Seminar Luncheons
    • Workshops
    • Minisymposia
    • Dinner Seminars
  • My Events
  • Past Events
• Organizations
  • Boston-PBSS Home
  • CACO-PBSS SF Bay Area
  • CACO-PBSS San Diego
  • Partner Organizations
• Sponsorship
  • Sponsorship Info
  • Vendor Show Instructions
  • Sponsorship Policies
  • Make a Special Payment
• Resources
  • Free Jobs-Listing
  • Ad Placement
  • Useful Scientific Links
• Contact Us
  • Contact Us
  • FAQs
• Login

CACO-Bay Area Quarterly seminar luncheons

Our popular seminar luncheons are held quarterly, normally from 11:00am to 1:00pm on Fridays. The venue is Crwone Plaza Hotel in Foster City, which is centrally located in the San Francisco Bay Area and readily accessible from major highways such as 101 and 92. Thanks to the generous financial support from close to 30 vendors each time, we have been able to provide the luncheons to our members free of charge. The attendance has been overwhelming, with ~300 scientists attending each time.

For information on the upcoming seminars, visit the home page.

Past seminar luncheons:

• Oct. 1, 2010: Utility of nanowire technology in oral drug delivery (Professor Tejle Desai, UCSF)
• May 21, 2010: Ligand-Binding Mass Spectrometry to Investigate Protein Drug Biotransformation, Direct Candidate Selection, and Corroborate Immunoassays (Michael Hall, Ph.D., Amgen)
• Feb. 19, 2010: Towards a Standardized Metabolomics Repository (Jointly with Bay Area Bioinformatics Forum) (Professor Oliver Fiehn, UC Davis)
• Dec 04, 2009: Use of Nano Particle Technology to Enhance Performance of Pharmaceutical Products (Niels Ryde, Ph.D., Elan Drug Technologies)
• Sept. 18, 2009: Drug Physical Form and its Importance in Drug Candidate Development (Michael Brandl, Ph.D., Roche)
• May 15, 2009: Prodrugs – How, when and why (Matthew Wright, Ph.D.; Adrian Ray, Ph.D., Gilead)
• Feb. 13, 2009: Strategies to Evaluate the Blood-Brain Barrier in Drug Discovery and Development (Xingrong Liu, Ph.D., Roche)
• Dec. 05, 2008: Metabolite identification in drug discovery and development. Are we getting our money's worth? (Cornelis Hop, Ph.D., Genentech)
• Sept. 19, 2008: Site Seeing in the World of Regulatory Affairs (Senior Manager, Genentech)
• May 23, 2008: Preclinical Toxicology Studies: Considerations in the Design, Implementation and Interpretation (Brian Rogers, Ph.D., Pacific BioDevelopment)
• Mar. 21, 2008: Accelerator Mass Spectrometry and Microdosing (John Vogel, Ph.D.)
• Nov. 30, 2007: Joint BAAC-BAPK/PD meeting: Utility of PK/PD Modeling in Drug development (Emil Samara, PhD, PharmaPolaris)
• Sept. 21, 2007:  Improving Medicines Through Active Transport  (Feng Xu, Ph.D., Xenoport)
• May 18, 2007: Bioanalytical Strategies for Antibody-Drug Conjugate Biopharmaceutical Development: Immunoassays and LC-MS Assays (Surinder Kaur, Ph.D., Genentech)
• Mar. 23, 2007: Regulated Bioanalysis - Crystal City Revisit  (Danlin Wu, Ph.D., Roche Palo Alto)
• Dec. 01, 2006: The Value (or Non-value) of in vitro ADME Tools in Picking the Perfect Drug Candidates (Mario Monshouwer, Ph.D., Roche Palo Alto)
• Sept. 22, 2006: Hsiao Dee Lieu, M.D. (Portola Pharmaceuticals), "Demystifying the Blackbox of Clinical Research and Development"
• June 09, 2006: Kathryn Woodburn, Ph.D. (Affymax): "Translational Preclinical Development"
• Mar. 31, 2006: Professor Joe Pesek (San Jose State University): "Recent Advances in Column Chemistry"
• Dec. 09, 2005: John Wang, Ph.D. (Genentech): "Pharmaceutics in Drug Development"
• Sept. 16, 2005: Mark Grillo, Ph.D. (Amgen San Francisco), "Metabolic activation and idiosyncratic drug toxicities"
• May 20, 2005: Ed Berger (Guidant), "Drug Eluting Stents and Stent Analysis"
• Mar. 25: May Lee, Ph.D. (Iconix), "Gene Expression Changes induced by Drug Treatment: Understanding Drug Off-target Effects and Drug Metabolism"
• Dec. 08, 2004: Professor Philip Crews (UC San Cruz), "The chemistry and art of wine making"
• Sept. 17: 2004: Ning Tang, Ph.D. (Agilent), "Recent technological developments in proteomic research"
• June 11, 2004: Haihong Zhou, Ph.D. (Surromed), "Global Differential Expression Profiling for Metabolic Biomarker Discovery: Advances and Challenges"
• Mar. 19, 2004: Robert Cass (Theravance), "Automation for today's Bioanalytical Laboratory -- Are we doing all we can?"
• Dec. 2003: Jim Zhang, Ph.D. (Affymax), "Characterization of PEGylated peptide drugs"
• Sept. 2003: Michael Kernan, Ph.D. (Gilead), "Application of Analytical Methods to Pharmaceutical Development"
• June 2003: Jim Bao, Ph.D. (Theravance), "Capillary electrophoresis in drug discovery and development"